Krka acquired 5,200 treasury shares in the total value of EUR 1,202,307 the Ljubljana Stock Exchange as follows: - on 13 March 2026: 1,194 shares at a VWAP of EUR 229.45, - on 16 March 2026: 1,194 ...

LJUBLJANA, Nov 21 (Reuters) - Slovenian pharmaceutical producer Krka made a group net profit of 171.9 million euros ($190.3 million) in the first nine months of 2019 versus 120.8 million in the same ...

Krka Group (LJSE:KRK) reported record first-half results for 2025 during its July 24 presentation, with sales exceeding €1 billion for the first time in a half-year period. The Slovenian ...

LJUBLJANA, Nov 9 (Reuters) - Slovenia's top pharmaceutical firm Krka said on Friday it would buy German generic drugs producer TAD Pharma for 97 million euros ($142.6 million), in its first venture ...

Ljubljana and Article 2 of the Commission Delegated Regulation (EU) 2016/1052 Krka, d. d., Novo mesto announces: With a reference to the public notice from 20 July 2023, Krka is publicly disclosing ...

Krka achieved record Q1 2025 sales of €522.1 million, representing a 7% increase year-over-year. More impressively, net profit soared by 51% to reach €152.5 million, driven by both operational ...

Laurus Labs has entered into an agreement with Slovenia-based drug manufacturer Krka to establish a joint venture (JV) firm in Hyderabad. Under the agreement, Krka will hold a 51% stake, while Laurus ...

Three Slovenian blue-chip companies - drug maker Krka, Nova Ljubljanska Banka (NLB), and energy company Petrol - started trading on the Vienna Stock Exchange’s international market segment, the bourse ...